Related Experiment Videos
Competitive RT-PCR to quantify CFTR mRNA in human endometrium
A Mularoni1, G L Adessi, F Arbez-Gindre
1Service de Biochimie, Centre Hospitalier Universitaire, Besançon, France.
Clinical Chemistry
|November 1, 1996
Summary
A new method accurately measures cystic fibrosis transmembrane conductance regulator (CFTR) mRNA in human endometrial tissue. This technique can help determine uterine receptivity and diagnose gynecological conditions.
Area of Science:
- Reproductive Biology
- Molecular Biology
- Gynecology
Background:
- Progesterone down-regulates cystic fibrosis transmembrane conductance regulator (CFTR) expression.
- CFTR expression levels may indicate endometrial receptivity for implantation.
- Accurate quantification of CFTR mRNA is needed for clinical applications.
Purpose of the Study:
- To develop a competitive reverse transcription-polymerase chain reaction (RT-PCR) assay for quantifying CFTR mRNA.
- To validate the assay's suitability for human endometrial samples.
Main Methods:
- A competitor RNA molecule was designed with a 20-nucleotide insertion.
- Competitive RT-PCR was performed on endometrial samples.
- Amplified products were analyzed using polyacrylamide gel electrophoresis.
Main Results:
- The assay demonstrated suitability for CFTR mRNA quantification.
- CFTR mRNA levels were measured in various menstrual cycle phases, endometriosis, and hyperplasia.
Conclusions:
- The developed competitive RT-PCR is a reliable method for measuring CFTR mRNA concentration.
- This assay can be used to assess endometrial receptivity and study CFTR expression in gynecological conditions.